Didier Communi

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Identification of an anti-inflammatory action of exosome release in P2Y4 loss-mediated cardioprotection.

Identification of an anti-inflammatory action of exosome release in P2Y4 loss-mediated cardioprotection.

Journal: Frontiers in pharmacology

Published: July 11, 2025

Corrigendum: Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss.

Corrigendum: Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss.

Journal: Frontiers in immunology

Published: October 05, 2022

Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.

Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.

Journal: Frontiers in pharmacology

Published: September 20, 2022

Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss.

Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss.

Journal: Frontiers in immunology

Published: July 29, 2022

UTP Regulates the Cardioprotective Action of Transplanted Stem Cells Derived From Mouse Cardiac Adipose Tissue.

UTP Regulates the Cardioprotective Action of Transplanted Stem Cells Derived From Mouse Cardiac Adipose Tissue.

Journal: Frontiers in pharmacology

Published: March 28, 2022

UTP is a regulator of in vitro and in vivo angiogenic properties of cardiac adipose-derived stem cells.

UTP is a regulator of in vitro and in vivo angiogenic properties of cardiac adipose-derived stem cells.

Journal: Purinergic signalling

Published: March 29, 2021

P2Y4, P2Y6 and P2Y11 receptors: From the early days of cloning to their function.

P2Y4, P2Y6 and P2Y11 receptors: From the early days of cloning to their function.

Journal: Biochemical pharmacology

Published: October 13, 2020

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

Journal: Scandinavian journal of rheumatology

Published: October 07, 2020

P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters.

P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters.

Journal: Stem cells and development

Published: December 13, 2019

Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation.

Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation.

Journal: Stem cells and development

Published: November 19, 2016

Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.

Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.

Journal: The Journal of biological chemistry

Published: August 06, 2015

Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation.

Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: January 18, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026